Share Price and Basic Stock Data
Last Updated: January 17, 2026, 7:07 am
| PEG Ratio | 2.88 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
ICRA Ltd, a prominent player in the Rating Services industry, reported a current price of ₹6,014, with a market capitalization of ₹5,809 Cr. The company’s revenue from operations for the fiscal year ending March 2025 stood at ₹498 Cr, reflecting a steady growth trajectory from ₹403 Cr in March 2023. In the quarterly breakdown, ICRA recorded sales of ₹105 Cr in September 2023, which rose to ₹115 Cr by December 2023, indicating a consistent upward trend. This growth is supported by a strategic approach to expanding its service offerings and maintaining a robust client base. The operating profit margin (OPM) was reported at 36%, showcasing the company’s ability to manage costs effectively while maximizing revenue. Over the past few years, ICRA’s sales growth has been resilient, with a total sales increase from ₹343 Cr in March 2022 to ₹403 Cr in March 2023, and projected further growth to ₹498 Cr in March 2025. This upward momentum in sales highlights ICRA’s strong market position and operational effectiveness.
Profitability and Efficiency Metrics
ICRA’s profitability metrics indicate a solid performance, with a net profit of ₹189 Cr reported for the trailing twelve months (TTM). The net profit margin stood at 34.37% for March 2025, reflecting strong cost management and revenue generation capabilities. The return on equity (ROE) was recorded at 16.8%, while the return on capital employed (ROCE) stood at 23.1%. These figures suggest that ICRA effectively utilizes its equity and capital to generate profits. The interest coverage ratio (ICR) was notably high at 53.12x, indicating that the company can comfortably meet its interest obligations, which is a significant strength in maintaining financial health. Additionally, the cash conversion cycle was reported at 35 days, demonstrating efficiency in converting investments into cash flow. However, the operating profit margin has shown some fluctuations, dipping to 26% in December 2023, which may warrant monitoring to ensure sustained profitability.
Balance Sheet Strength and Financial Ratios
ICRA’s balance sheet demonstrates strong financial health, with total assets reported at ₹1,292 Cr as of March 2025, against total liabilities of ₹1,292 Cr, indicating a balanced capital structure. The reserves have consistently increased, standing at ₹1,078 Cr in September 2025, up from ₹941 Cr in March 2023, showcasing the company’s ability to retain earnings for future growth. The company’s borrowings are minimal, recorded at ₹12 Cr, which further strengthens its financial position. The price-to-book value (P/BV) ratio stood at 5.06x, suggesting that the stock is valued at a premium compared to its book value, reflecting investor confidence in ICRA’s growth potential. Furthermore, the current ratio is reported at 6.37x, indicating a strong liquidity position, which is significantly higher than typical sector norms. This high liquidity provides a cushion against short-term obligations and enhances financial stability.
Shareholding Pattern and Investor Confidence
ICRA’s shareholding pattern reveals a stable structure, with promoters holding 51.86% of the equity shares, ensuring control over the company’s strategic direction. Institutional investors, including foreign institutional investors (FIIs) and domestic institutional investors (DIIs), hold 6.87% and 26.15% of shares, respectively, indicating a diversified investor base. The public shareholding stands at 14.82%, reflecting healthy public interest in the company. The number of shareholders has increased from 16,684 in December 2022 to 21,818 in September 2025, highlighting growing investor confidence. The dividend payout ratio for March 2025 was reported at 56.58%, which is a positive signal to investors regarding the company’s commitment to returning value to shareholders. This consistent support from institutional and retail investors suggests a robust outlook for ICRA, despite potential market volatility.
Outlook, Risks, and Final Insight
Looking ahead, ICRA is poised for continued growth, supported by its strong market position and increasing revenue trends. However, risks such as economic downturns affecting client funding and competitive pressures in the rating services space could impact future performance. The company’s ability to maintain its operating margins amidst rising costs will be crucial. Another risk includes potential regulatory changes that could affect the rating industry. Nevertheless, ICRA’s strong balance sheet, efficient operations, and solid profitability metrics provide a strong foundation for navigating these challenges. Should the company continue to innovate and adapt to market demands, it could sustain its growth trajectory. Conversely, failure to effectively manage operational costs or respond to market shifts could hinder its performance. Overall, ICRA represents a compelling investment opportunity, but vigilance regarding external economic factors and internal efficiency will be essential for long-term success.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| ICRA Ltd | 5,884 Cr. | 6,097 | 7,135/5,015 | 31.3 | 1,127 | 0.98 % | 23.1 % | 16.8 % | 10.0 |
| CARE Ratings Ltd | 4,849 Cr. | 1,614 | 1,965/1,052 | 31.7 | 288 | 1.12 % | 24.6 % | 18.0 % | 10.0 |
| Industry Average | 5,366.50 Cr | 3,855.50 | 31.50 | 707.50 | 1.05% | 23.85% | 17.40% | 10.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 99 | 103 | 109 | 103 | 105 | 115 | 124 | 115 | 126 | 121 | 136 | 124 | 137 |
| Expenses | 63 | 67 | 71 | 68 | 71 | 84 | 74 | 80 | 85 | 79 | 77 | 85 | 88 |
| Operating Profit | 36 | 36 | 38 | 35 | 34 | 30 | 50 | 35 | 41 | 42 | 59 | 40 | 49 |
| OPM % | 36% | 35% | 35% | 34% | 32% | 26% | 40% | 31% | 33% | 35% | 43% | 32% | 36% |
| Other Income | 13 | 15 | 16 | 18 | 16 | 17 | 24 | 18 | 20 | 19 | 21 | 24 | 21 |
| Interest | 0 | 0 | 0 | 0 | 0 | 3 | 7 | 2 | 0 | 1 | 1 | 2 | 1 |
| Depreciation | 2 | 3 | 3 | 2 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Profit before tax | 46 | 48 | 51 | 50 | 47 | 41 | 62 | 47 | 57 | 56 | 74 | 58 | 64 |
| Tax % | 19% | 18% | 24% | 18% | 32% | 20% | 24% | 24% | 35% | 24% | 24% | 27% | 25% |
| Net Profit | 37 | 39 | 39 | 41 | 32 | 32 | 47 | 36 | 37 | 42 | 56 | 43 | 48 |
| EPS in Rs | 38.06 | 40.29 | 39.76 | 41.77 | 32.92 | 33.31 | 48.56 | 36.80 | 38.05 | 43.55 | 57.75 | 43.97 | 49.54 |
Last Updated: January 1, 2026, 9:46 am
Below is a detailed analysis of the quarterly data for ICRA Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 137.00 Cr.. The value appears strong and on an upward trend. It has increased from 124.00 Cr. (Jun 2025) to 137.00 Cr., marking an increase of 13.00 Cr..
- For Expenses, as of Sep 2025, the value is 88.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 85.00 Cr. (Jun 2025) to 88.00 Cr., marking an increase of 3.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 49.00 Cr.. The value appears strong and on an upward trend. It has increased from 40.00 Cr. (Jun 2025) to 49.00 Cr., marking an increase of 9.00 Cr..
- For OPM %, as of Sep 2025, the value is 36.00%. The value appears strong and on an upward trend. It has increased from 32.00% (Jun 2025) to 36.00%, marking an increase of 4.00%.
- For Other Income, as of Sep 2025, the value is 21.00 Cr.. The value appears to be declining and may need further review. It has decreased from 24.00 Cr. (Jun 2025) to 21.00 Cr., marking a decrease of 3.00 Cr..
- For Interest, as of Sep 2025, the value is 1.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.00 Cr. (Jun 2025) to 1.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Sep 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 4.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 64.00 Cr.. The value appears strong and on an upward trend. It has increased from 58.00 Cr. (Jun 2025) to 64.00 Cr., marking an increase of 6.00 Cr..
- For Tax %, as of Sep 2025, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Jun 2025) to 25.00%, marking a decrease of 2.00%.
- For Net Profit, as of Sep 2025, the value is 48.00 Cr.. The value appears strong and on an upward trend. It has increased from 43.00 Cr. (Jun 2025) to 48.00 Cr., marking an increase of 5.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 49.54. The value appears strong and on an upward trend. It has increased from 43.97 (Jun 2025) to 49.54, marking an increase of 5.57.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:13 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 283 | 322 | 341 | 333 | 309 | 328 | 321 | 301 | 343 | 403 | 446 | 498 | 518 |
| Expenses | 197 | 252 | 240 | 231 | 194 | 215 | 225 | 220 | 222 | 260 | 297 | 320 | 329 |
| Operating Profit | 86 | 70 | 101 | 102 | 115 | 113 | 96 | 81 | 121 | 143 | 149 | 178 | 190 |
| OPM % | 30% | 22% | 30% | 31% | 37% | 34% | 30% | 27% | 35% | 35% | 33% | 36% | 37% |
| Other Income | 19 | 42 | 27 | 39 | 49 | 45 | 48 | 43 | 41 | 50 | 75 | 77 | 85 |
| Interest | 1 | 2 | 1 | 0 | 0 | 0 | 2 | 2 | 2 | 1 | 10 | 5 | 5 |
| Depreciation | 6 | 10 | 10 | 9 | 8 | 6 | 10 | 10 | 8 | 10 | 13 | 16 | 17 |
| Profit before tax | 98 | 100 | 118 | 132 | 157 | 152 | 131 | 112 | 152 | 181 | 200 | 234 | 253 |
| Tax % | 30% | 35% | 35% | 33% | 35% | 30% | 26% | 26% | 25% | 25% | 24% | 27% | |
| Net Profit | 69 | 66 | 76 | 89 | 101 | 106 | 97 | 83 | 114 | 137 | 152 | 171 | 189 |
| EPS in Rs | 68.93 | 65.45 | 76.24 | 89.29 | 101.68 | 109.21 | 99.66 | 84.61 | 116.35 | 140.13 | 156.55 | 176.15 | 194.81 |
| Dividend Payout % | 33% | 37% | 33% | 30% | 29% | 27% | 27% | 32% | 24% | 93% | 64% | 34% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -4.35% | 15.15% | 17.11% | 13.48% | 4.95% | -8.49% | -14.43% | 37.35% | 20.18% | 10.95% | 12.50% |
| Change in YoY Net Profit Growth (%) | 0.00% | 19.50% | 1.95% | -3.62% | -8.53% | -13.44% | -5.94% | 51.78% | -17.17% | -9.23% | 1.55% |
ICRA Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 9% |
| 3 Years: | 13% |
| TTM: | 11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 12% |
| 3 Years: | 15% |
| TTM: | 21% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 18% |
| 3 Years: | 18% |
| 1 Year: | 0% |
| Return on Equity | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 15% |
| 3 Years: | 16% |
| Last Year: | 17% |
Last Updated: September 5, 2025, 6:45 am
Balance Sheet
Last Updated: December 4, 2025, 1:24 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 378 | 419 | 466 | 539 | 645 | 631 | 692 | 748 | 834 | 941 | 967 | 1,044 | 1,078 |
| Borrowings | 16 | 10 | 0 | 0 | 0 | 0 | 0 | 17 | 14 | 13 | 13 | 13 | 12 |
| Other Liabilities | 109 | 144 | 151 | 111 | 116 | 128 | 144 | 121 | 121 | 138 | 195 | 225 | 265 |
| Total Liabilities | 513 | 583 | 627 | 660 | 771 | 769 | 846 | 896 | 978 | 1,101 | 1,184 | 1,292 | 1,364 |
| Fixed Assets | 89 | 91 | 92 | 37 | 36 | 34 | 54 | 46 | 46 | 47 | 91 | 90 | 90 |
| CWIP | 7 | 0 | 1 | 1 | 0 | 1 | 2 | 3 | 2 | 1 | 1 | 4 | 0 |
| Investments | 277 | 257 | 185 | 311 | 338 | 182 | 104 | 177 | 454 | 689 | 813 | 773 | 911 |
| Other Assets | 140 | 234 | 350 | 312 | 396 | 552 | 685 | 669 | 478 | 364 | 278 | 426 | 363 |
| Total Assets | 513 | 583 | 627 | 660 | 771 | 769 | 846 | 896 | 978 | 1,101 | 1,184 | 1,292 | 1,364 |
Below is a detailed analysis of the balance sheet data for ICRA Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 10.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,078.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,044.00 Cr. (Mar 2025) to 1,078.00 Cr., marking an increase of 34.00 Cr..
- For Borrowings, as of Sep 2025, the value is 12.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 13.00 Cr. (Mar 2025) to 12.00 Cr., marking a decrease of 1.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 265.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 225.00 Cr. (Mar 2025) to 265.00 Cr., marking an increase of 40.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,364.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,292.00 Cr. (Mar 2025) to 1,364.00 Cr., marking an increase of 72.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 90.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 90.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 4.00 Cr..
- For Investments, as of Sep 2025, the value is 911.00 Cr.. The value appears strong and on an upward trend. It has increased from 773.00 Cr. (Mar 2025) to 911.00 Cr., marking an increase of 138.00 Cr..
- For Other Assets, as of Sep 2025, the value is 363.00 Cr.. The value appears to be declining and may need further review. It has decreased from 426.00 Cr. (Mar 2025) to 363.00 Cr., marking a decrease of 63.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,364.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,292.00 Cr. (Mar 2025) to 1,364.00 Cr., marking an increase of 72.00 Cr..
Notably, the Reserves (1,078.00 Cr.) exceed the Borrowings (12.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 70.00 | 60.00 | 101.00 | 102.00 | 115.00 | 113.00 | 96.00 | 64.00 | 107.00 | 130.00 | 136.00 | 165.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 55 | 61 | 51 | 37 | 48 | 38 | 65 | 58 | 28 | 34 | 42 | 35 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 55 | 61 | 51 | 37 | 48 | 38 | 65 | 58 | 28 | 34 | 42 | 35 |
| Working Capital Days | -54 | -64 | -66 | -45 | -41 | -44 | -2 | -48 | -55 | -64 | -61 | -75 |
| ROCE % | 23% | 21% | 24% | 26% | 25% | 23% | 20% | 15% | 19% | 20% | 21% | 23% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Nippon India Small Cap Fund | 626,192 | 0.57 | 388.11 | N/A | N/A | N/A |
| Parag Parikh Flexi Cap Fund | 287,393 | 0.14 | 178.13 | 422,587 | 2025-12-08 03:45:20 | -31.99% |
| Canara Robeco Small Cap Fund | 217,766 | 1.03 | 134.97 | 168,320 | 2025-12-08 03:45:20 | 29.38% |
| Aditya Birla Sun Life MNC Fund | 161,517 | 2.76 | 100.11 | 161,756 | 2025-12-15 02:45:37 | -0.15% |
| SBI Banking & Financial Services Fund | 153,760 | 0.97 | 95.3 | N/A | N/A | N/A |
| SBI Infrastructure Fund | 125,000 | 1.62 | 77.48 | N/A | N/A | N/A |
| JM Flexicap Fund | 119,873 | 1.24 | 74.3 | 121,828 | 2025-12-14 03:26:00 | -1.6% |
| ICICI Prudential Smallcap Fund | 80,067 | 0.59 | 49.63 | N/A | N/A | N/A |
| ICICI Prudential Childrens Fund | 20,972 | 0.91 | 13 | N/A | N/A | N/A |
| Parag Parikh ELSS Tax Saver Fund | 5,803 | 0.06 | 3.6 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 176.73 | 157.07 | 140.59 | 116.74 | 84.89 |
| Diluted EPS (Rs.) | 176.50 | 156.99 | 140.59 | 116.74 | 84.89 |
| Cash EPS (Rs.) | 194.38 | 171.69 | 151.85 | 125.73 | 95.95 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1091.29 | 1016.43 | 989.44 | 878.36 | 788.52 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1091.29 | 1016.43 | 989.44 | 878.36 | 788.52 |
| Revenue From Operations / Share (Rs.) | 516.02 | 462.24 | 417.80 | 355.19 | 311.94 |
| PBDIT / Share (Rs.) | 264.39 | 231.82 | 199.41 | 167.29 | 128.46 |
| PBIT / Share (Rs.) | 247.40 | 217.87 | 189.23 | 159.20 | 118.18 |
| PBT / Share (Rs.) | 242.43 | 207.08 | 187.77 | 157.58 | 116.05 |
| Net Profit / Share (Rs.) | 177.39 | 157.74 | 141.67 | 117.64 | 85.67 |
| NP After MI And SOA / Share (Rs.) | 176.15 | 156.56 | 140.12 | 116.35 | 84.61 |
| PBDIT Margin (%) | 51.23 | 50.15 | 47.72 | 47.09 | 41.18 |
| PBIT Margin (%) | 47.94 | 47.13 | 45.29 | 44.82 | 37.88 |
| PBT Margin (%) | 46.98 | 44.80 | 44.94 | 44.36 | 37.20 |
| Net Profit Margin (%) | 34.37 | 34.12 | 33.90 | 33.11 | 27.46 |
| NP After MI And SOA Margin (%) | 34.13 | 33.86 | 33.53 | 32.75 | 27.12 |
| Return on Networth / Equity (%) | 16.14 | 15.47 | 14.23 | 13.31 | 10.77 |
| Return on Capital Employeed (%) | 21.37 | 20.30 | 18.84 | 17.80 | 14.62 |
| Return On Assets (%) | 13.13 | 12.72 | 12.28 | 11.47 | 9.11 |
| Asset Turnover Ratio (%) | 0.40 | 0.38 | 0.24 | 0.23 | 0.23 |
| Current Ratio (X) | 6.37 | 4.32 | 4.29 | 3.77 | 4.26 |
| Quick Ratio (X) | 6.37 | 4.32 | 4.29 | 3.77 | 4.26 |
| Dividend Payout Ratio (NP) (%) | 56.58 | 82.76 | 19.91 | 23.12 | 31.80 |
| Dividend Payout Ratio (CP) (%) | 51.60 | 75.99 | 18.56 | 21.62 | 28.36 |
| Earning Retention Ratio (%) | 43.42 | 17.24 | 80.09 | 76.88 | 68.20 |
| Cash Earning Retention Ratio (%) | 48.40 | 24.01 | 81.44 | 78.38 | 71.64 |
| Interest Coverage Ratio (X) | 53.12 | 21.50 | 136.25 | 103.41 | 60.27 |
| Interest Coverage Ratio (Post Tax) (X) | 36.64 | 15.63 | 97.80 | 73.71 | 41.19 |
| Enterprise Value (Cr.) | 5054.70 | 5105.59 | 4025.55 | 3803.03 | 2773.34 |
| EV / Net Operating Revenue (X) | 10.15 | 11.44 | 9.98 | 11.09 | 9.21 |
| EV / EBITDA (X) | 19.81 | 22.82 | 20.92 | 23.55 | 22.37 |
| MarketCap / Net Operating Revenue (X) | 10.70 | 11.78 | 10.57 | 11.99 | 10.53 |
| Retention Ratios (%) | 43.41 | 17.23 | 80.08 | 76.87 | 68.19 |
| Price / BV (X) | 5.06 | 5.38 | 4.49 | 4.87 | 4.18 |
| Price / Net Operating Revenue (X) | 10.70 | 11.78 | 10.57 | 11.99 | 10.53 |
| EarningsYield | 0.03 | 0.02 | 0.03 | 0.02 | 0.02 |
After reviewing the key financial ratios for ICRA Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 176.73. This value is within the healthy range. It has increased from 157.07 (Mar 24) to 176.73, marking an increase of 19.66.
- For Diluted EPS (Rs.), as of Mar 25, the value is 176.50. This value is within the healthy range. It has increased from 156.99 (Mar 24) to 176.50, marking an increase of 19.51.
- For Cash EPS (Rs.), as of Mar 25, the value is 194.38. This value is within the healthy range. It has increased from 171.69 (Mar 24) to 194.38, marking an increase of 22.69.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,091.29. It has increased from 1,016.43 (Mar 24) to 1,091.29, marking an increase of 74.86.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,091.29. It has increased from 1,016.43 (Mar 24) to 1,091.29, marking an increase of 74.86.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 516.02. It has increased from 462.24 (Mar 24) to 516.02, marking an increase of 53.78.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 264.39. This value is within the healthy range. It has increased from 231.82 (Mar 24) to 264.39, marking an increase of 32.57.
- For PBIT / Share (Rs.), as of Mar 25, the value is 247.40. This value is within the healthy range. It has increased from 217.87 (Mar 24) to 247.40, marking an increase of 29.53.
- For PBT / Share (Rs.), as of Mar 25, the value is 242.43. This value is within the healthy range. It has increased from 207.08 (Mar 24) to 242.43, marking an increase of 35.35.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 177.39. This value is within the healthy range. It has increased from 157.74 (Mar 24) to 177.39, marking an increase of 19.65.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 176.15. This value is within the healthy range. It has increased from 156.56 (Mar 24) to 176.15, marking an increase of 19.59.
- For PBDIT Margin (%), as of Mar 25, the value is 51.23. This value is within the healthy range. It has increased from 50.15 (Mar 24) to 51.23, marking an increase of 1.08.
- For PBIT Margin (%), as of Mar 25, the value is 47.94. This value exceeds the healthy maximum of 20. It has increased from 47.13 (Mar 24) to 47.94, marking an increase of 0.81.
- For PBT Margin (%), as of Mar 25, the value is 46.98. This value is within the healthy range. It has increased from 44.80 (Mar 24) to 46.98, marking an increase of 2.18.
- For Net Profit Margin (%), as of Mar 25, the value is 34.37. This value exceeds the healthy maximum of 10. It has increased from 34.12 (Mar 24) to 34.37, marking an increase of 0.25.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 34.13. This value exceeds the healthy maximum of 20. It has increased from 33.86 (Mar 24) to 34.13, marking an increase of 0.27.
- For Return on Networth / Equity (%), as of Mar 25, the value is 16.14. This value is within the healthy range. It has increased from 15.47 (Mar 24) to 16.14, marking an increase of 0.67.
- For Return on Capital Employeed (%), as of Mar 25, the value is 21.37. This value is within the healthy range. It has increased from 20.30 (Mar 24) to 21.37, marking an increase of 1.07.
- For Return On Assets (%), as of Mar 25, the value is 13.13. This value is within the healthy range. It has increased from 12.72 (Mar 24) to 13.13, marking an increase of 0.41.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.40. It has increased from 0.38 (Mar 24) to 0.40, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 6.37. This value exceeds the healthy maximum of 3. It has increased from 4.32 (Mar 24) to 6.37, marking an increase of 2.05.
- For Quick Ratio (X), as of Mar 25, the value is 6.37. This value exceeds the healthy maximum of 2. It has increased from 4.32 (Mar 24) to 6.37, marking an increase of 2.05.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 56.58. This value exceeds the healthy maximum of 50. It has decreased from 82.76 (Mar 24) to 56.58, marking a decrease of 26.18.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 51.60. This value exceeds the healthy maximum of 50. It has decreased from 75.99 (Mar 24) to 51.60, marking a decrease of 24.39.
- For Earning Retention Ratio (%), as of Mar 25, the value is 43.42. This value is within the healthy range. It has increased from 17.24 (Mar 24) to 43.42, marking an increase of 26.18.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 48.40. This value is within the healthy range. It has increased from 24.01 (Mar 24) to 48.40, marking an increase of 24.39.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 53.12. This value is within the healthy range. It has increased from 21.50 (Mar 24) to 53.12, marking an increase of 31.62.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 36.64. This value is within the healthy range. It has increased from 15.63 (Mar 24) to 36.64, marking an increase of 21.01.
- For Enterprise Value (Cr.), as of Mar 25, the value is 5,054.70. It has decreased from 5,105.59 (Mar 24) to 5,054.70, marking a decrease of 50.89.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 10.15. This value exceeds the healthy maximum of 3. It has decreased from 11.44 (Mar 24) to 10.15, marking a decrease of 1.29.
- For EV / EBITDA (X), as of Mar 25, the value is 19.81. This value exceeds the healthy maximum of 15. It has decreased from 22.82 (Mar 24) to 19.81, marking a decrease of 3.01.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 10.70. This value exceeds the healthy maximum of 3. It has decreased from 11.78 (Mar 24) to 10.70, marking a decrease of 1.08.
- For Retention Ratios (%), as of Mar 25, the value is 43.41. This value is within the healthy range. It has increased from 17.23 (Mar 24) to 43.41, marking an increase of 26.18.
- For Price / BV (X), as of Mar 25, the value is 5.06. This value exceeds the healthy maximum of 3. It has decreased from 5.38 (Mar 24) to 5.06, marking a decrease of 0.32.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 10.70. This value exceeds the healthy maximum of 3. It has decreased from 11.78 (Mar 24) to 10.70, marking a decrease of 1.08.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.03, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in ICRA Ltd:
- Net Profit Margin: 34.37%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 21.37% (Industry Average ROCE: 23.85%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 16.14% (Industry Average ROE: 17.4%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 36.64
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 6.37
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 31.3 (Industry average Stock P/E: 31.5)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 34.37%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Rating Services | B-710, Statesman House, New Delhi Delhi 110001 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Palamadai Sundararajan Jayakumar | Non Exe.Chairman&Ind.Director |
| Mr. Ramnath Krishnan | Managing Director & Group CEO |
| Ms. Wendy Huay Huay Cheong | Non Exe.Non Ind.Director |
| Ms. Shivani Priya Mohini Kak | Non Exe.Non Ind.Director |
| Mr. Stephen Arthur Long | Non Exe.Non Ind.Director |
| Mr. Brian Joseph Cahill | Non Exe.Non Ind.Director |
| Mr. Pradip Kanakia | Independent Director |
| Ms. Anuranjita Kumar | Independent Director |
FAQ
What is the intrinsic value of ICRA Ltd?
ICRA Ltd's intrinsic value (as of 18 January 2026) is ₹5307.27 which is 12.95% lower the current market price of ₹6,097.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹5,884 Cr. market cap, FY2025-2026 high/low of ₹7,135/5,015, reserves of ₹1,078 Cr, and liabilities of ₹1,364 Cr.
What is the Market Cap of ICRA Ltd?
The Market Cap of ICRA Ltd is 5,884 Cr..
What is the current Stock Price of ICRA Ltd as on 18 January 2026?
The current stock price of ICRA Ltd as on 18 January 2026 is ₹6,097.
What is the High / Low of ICRA Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of ICRA Ltd stocks is ₹7,135/5,015.
What is the Stock P/E of ICRA Ltd?
The Stock P/E of ICRA Ltd is 31.3.
What is the Book Value of ICRA Ltd?
The Book Value of ICRA Ltd is 1,127.
What is the Dividend Yield of ICRA Ltd?
The Dividend Yield of ICRA Ltd is 0.98 %.
What is the ROCE of ICRA Ltd?
The ROCE of ICRA Ltd is 23.1 %.
What is the ROE of ICRA Ltd?
The ROE of ICRA Ltd is 16.8 %.
What is the Face Value of ICRA Ltd?
The Face Value of ICRA Ltd is 10.0.